Open Access
- 3 August 2007
- journal article
- case report
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 147
Abstract
Background: The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration errors are increasingly recognised to be a common pitfall of PET/CT studies. Case Presentation: We report a patient with a germ cell tumour of the testis, who underwent a PET/CT scan to detect the site of relapse with a view to surgical removal. However, the PET/CT scan mislocalised the tumour site to be within the T2 vertebral body. A subsequent endoscopic ultrasound scan however showed the tumour to be anterior to the vertebral body, which was confirmed at surgery. Conclusion: In this report, we highlight the artefactual mislocalisation errors which may occur with PET/CT imaging, and the need to review and verify these scans.Keywords
This publication has 14 references indexed in Scilit:
- Tumor Lesion DetectionJournal of Computer Assisted Tomography, 2005
- Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imagingSeminars in Nuclear Medicine, 2004
- 2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET TrialJournal of Clinical Oncology, 2004
- Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumoursBritish Journal of Cancer, 2004
- Whole-body FDG-PET imaging in the management of patients with cancerSeminars in Nuclear Medicine, 2002
- Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapseBritish Journal of Cancer, 2000
- A combined PET/CT scanner for clinical oncology.2000
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18) - NONTOXIC TRACER FOR RAPID TUMOR-DETECTION1980